MSC-EVs from both MPN patients and healthy donors could increase cell viability of CD34+ HPCs and MSC-EVs from MPN patients could increase the number of granulocyte-monocyte colony forming unit (CFU-GM) from neoplastic CD34+ HPCs in the co-culture system.149. The gene discussed is CD34; the disease is myeloproliferative disorder.